Search images on Google      Product Monograph

Active Ingredients:

• asfotase alfa, 40 MG/ML

DIN: 02444615

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: 18MG/0.45 ML SINGLE USE VIAL

Schedule: Prescription

Company: ALEXION PHARMA GMBH

ATC:

• A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO, Wiki)
• A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO)
• A16AB - Enzymes (ATC, WHO)
• A16AB13 - ASFOTASE ALFA (WHO)

 

External Links for Strensiq:

Search on Google

• Strensiq side effects
• Strensiq dosage
• asfotase alfa side effects
• asfotase alfa dosage